Jiangsu Kanion Pharmaceutical Co.,Ltd.

SHSE:600557 Stock Report

Market Cap: CN¥9.8b

Jiangsu Kanion PharmaceuticalLtd Past Earnings Performance

Past criteria checks 5/6

Jiangsu Kanion PharmaceuticalLtd has been growing earnings at an average annual rate of 3.7%, while the Pharmaceuticals industry saw earnings growing at 9.2% annually. Revenues have been growing at an average rate of 3.9% per year. Jiangsu Kanion PharmaceuticalLtd's return on equity is 10%, and it has net margins of 11.1%.

Key information

3.7%

Earnings growth rate

4.2%

EPS growth rate

Pharmaceuticals Industry Growth10.9%
Revenue growth rate3.9%
Return on equity10.0%
Net Margin11.1%
Last Earnings Update31 Mar 2024

Recent past performance updates

Shareholders Can Be Confident That Jiangsu Kanion PharmaceuticalLtd's (SHSE:600557) Earnings Are High Quality

Apr 25
Shareholders Can Be Confident That Jiangsu Kanion PharmaceuticalLtd's (SHSE:600557) Earnings Are High Quality

Recent updates

Here's Why Jiangsu Kanion PharmaceuticalLtd (SHSE:600557) Has Caught The Eye Of Investors

May 21
Here's Why Jiangsu Kanion PharmaceuticalLtd (SHSE:600557) Has Caught The Eye Of Investors

Shareholders Can Be Confident That Jiangsu Kanion PharmaceuticalLtd's (SHSE:600557) Earnings Are High Quality

Apr 25
Shareholders Can Be Confident That Jiangsu Kanion PharmaceuticalLtd's (SHSE:600557) Earnings Are High Quality

Jiangsu Kanion Pharmaceutical Co.,Ltd.'s (SHSE:600557) Share Price Boosted 34% But Its Business Prospects Need A Lift Too

Mar 04
Jiangsu Kanion Pharmaceutical Co.,Ltd.'s (SHSE:600557) Share Price Boosted 34% But Its Business Prospects Need A Lift Too

Jiangsu Kanion Pharmaceutical Co.,Ltd. (SHSE:600557) Shares Fly 34% But Investors Aren't Buying For Growth

Mar 04
Jiangsu Kanion Pharmaceutical Co.,Ltd. (SHSE:600557) Shares Fly 34% But Investors Aren't Buying For Growth

Revenue & Expenses Breakdown

How Jiangsu Kanion PharmaceuticalLtd makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SHSE:600557 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 244,8745432,268787
31 Dec 234,8685372,284772
30 Sep 234,7215032,286679
30 Jun 234,8074992,313692
31 Mar 234,6254662,221650
31 Dec 224,3514342,060606
30 Sep 224,1903951,965600
30 Jun 223,9773721,887560
31 Mar 223,8653471,831540
31 Dec 213,6493211,745499
30 Sep 213,3442821,598430
30 Jun 213,2542781,572403
31 Mar 213,0752671,503399
31 Dec 203,0322631,457380
30 Sep 203,4713211,714376
30 Jun 203,8504091,955370
31 Mar 204,3054792,219422
31 Dec 194,5665072,457443
30 Sep 194,4354802,433416
30 Jun 194,2424552,314378
31 Mar 194,0084282,172313
31 Dec 183,8254142,041290
30 Sep 183,6193811,937261
30 Jun 183,4573841,648416
31 Mar 183,4013821,708318
31 Dec 173,2753741,700237
30 Sep 173,1363821,597202
30 Jun 173,1613741,8690
31 Mar 173,0713781,8090
31 Dec 163,0003741,7480
30 Sep 162,9603671,7290
30 Jun 162,8963631,6660
31 Mar 162,8613631,6230
31 Dec 152,8203621,6010
30 Sep 152,8153581,6060
30 Jun 152,7553491,5550
31 Mar 152,6313291,4740
31 Dec 142,5633201,4360
30 Sep 142,4773241,3570
30 Jun 142,4183231,3420
31 Mar 142,3383111,3110
31 Dec 132,2302971,2600
30 Sep 132,1762781,2570
30 Jun 132,1172701,1890

Quality Earnings: 600557 has high quality earnings.

Growing Profit Margin: 600557's current net profit margins (11.1%) are higher than last year (10.1%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 600557's earnings have grown by 3.7% per year over the past 5 years.

Accelerating Growth: 600557's earnings growth over the past year (16.6%) exceeds its 5-year average (3.7% per year).

Earnings vs Industry: 600557 earnings growth over the past year (16.6%) exceeded the Pharmaceuticals industry -0.8%.


Return on Equity

High ROE: 600557's Return on Equity (10%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.